Reply to Arends and Harkisoen

Clin Infect Dis. 2015 Jan 15;60(2):324-5. doi: 10.1093/cid/ciu800. Epub 2014 Oct 13.

Authors

Anna Linnér¹, Jan Sjölin², Jessica Darenberg³, Birgitta Henriques-Normark⁴, Anna Norrby-Teglund¹

Affiliations

¹ Center for Infectious Medicine, Karolinska Institutet.
² Department of Infectious Diseases, Uppsala University.
³ Public Health Agency of Sweden.
⁴ Department of Infectious Diseases, Uppsala University Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm Karolinska University Hospital, Solna, Sweden.

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Humans
Immunoglobulins, Intravenous / therapeutic use*
Male
Shock, Septic / therapy*
Streptococcal Infections / therapy*

Substances

Immunoglobulins, Intravenous